187 related articles for article (PubMed ID: 34101138)
1. Individual Participant Symptom Responses to Intra-Articular Lorecivivint in Knee Osteoarthritis: Post Hoc Analysis of a Phase 2B Trial.
Tambiah JRS; Kennedy S; Swearingen CJ; Simsek I; Yazici Y; Farr J; Conaghan PG
Rheumatol Ther; 2021 Jun; 8(2):973-985. PubMed ID: 34101138
[TBL] [Abstract][Full Text] [Related]
2. A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis.
Yazici Y; McAlindon TE; Gibofsky A; Lane NE; Lattermann C; Skrepnik N; Swearingen CJ; Simsek I; Ghandehari H; DiFrancesco A; Gibbs J; Tambiah JRS; Hochberg MC
Osteoarthritis Cartilage; 2021 May; 29(5):654-666. PubMed ID: 33588087
[TBL] [Abstract][Full Text] [Related]
3. Comparing Patient-Reported Outcomes From Sham and Saline-Based Placebo Injections for Knee Osteoarthritis: Data From a Randomized Clinical Trial of Lorecivivint.
Tambiah JRS; Simsek I; Swearingen CJ; Kennedy S; Cole BJ; McAlindon TE; Yazici Y
Am J Sports Med; 2022 Mar; 50(3):630-636. PubMed ID: 35005990
[TBL] [Abstract][Full Text] [Related]
4. Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial.
Yazici Y; McAlindon TE; Gibofsky A; Lane NE; Clauw D; Jones M; Bergfeld J; Swearingen CJ; DiFrancesco A; Simsek I; Tambiah J; Hochberg MC
Arthritis Rheumatol; 2020 Oct; 72(10):1694-1706. PubMed ID: 32432388
[TBL] [Abstract][Full Text] [Related]
5. Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm Study.
Fineman MS; McAlindon TE; Lattermann C; Swearingen CJ; Kennedy S; Lopez VA; Simsek I; Tambiah JRS; Yazici Y
Rheumatol Ther; 2023 Dec; 10(6):1741-1752. PubMed ID: 37902943
[TBL] [Abstract][Full Text] [Related]
6. Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales.
Ross E; Katz NP; Conaghan PG; Kivitz A; Turk DC; Spitzer AI; Jones DG; Lanier RK; Cinar A; Lufkin J; Kelley SD
Pain Ther; 2022 Mar; 11(1):289-302. PubMed ID: 34791634
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of intra-articular injection of tropomyosin receptor kinase A inhibitor in painful knee osteoarthritis: a randomized, double-blind and placebo-controlled study.
Krupka E; Jiang GL; Jan C
Osteoarthritis Cartilage; 2019 Nov; 27(11):1599-1607. PubMed ID: 31351965
[TBL] [Abstract][Full Text] [Related]
8. A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.
Yazici Y; McAlindon TE; Fleischmann R; Gibofsky A; Lane NE; Kivitz AJ; Skrepnik N; Armas E; Swearingen CJ; DiFrancesco A; Tambiah JRS; Hood J; Hochberg MC
Osteoarthritis Cartilage; 2017 Oct; 25(10):1598-1606. PubMed ID: 28711582
[TBL] [Abstract][Full Text] [Related]
9. A novel diclofenac gel (AMZ001) applied once or twice daily in subjects with painful knee osteoarthritis: A randomized, placebo-controlled clinical trial.
Bihlet AR; Byrjalsen I; Simon LS; Carrara D; Delpy L; Derne C
Semin Arthritis Rheum; 2020 Dec; 50(6):1203-1213. PubMed ID: 33059293
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?
Berenbaum F; Langford R; Perrot S; Miki K; Blanco FJ; Yamabe T; Isogawa N; Junor R; Carey W; Viktrup L; West CR; Brown MT; Verburg KM
Eur J Pain; 2021 Aug; 25(7):1525-1539. PubMed ID: 33728717
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the use of intra-articular injections as a treatment for painful hip osteoarthritis: a randomized, double-blind, multicenter, parallel-group study comparing a single 6-mL injection of hylan G-F 20 with saline.
Brander V; Skrepnik N; Petrella RJ; Jiang GL; Accomando B; Vardanyan A
Osteoarthritis Cartilage; 2019 Jan; 27(1):59-70. PubMed ID: 30223023
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment.
Deshmukh V; O'Green AL; Bossard C; Seo T; Lamangan L; Ibanez M; Ghias A; Lai C; Do L; Cho S; Cahiwat J; Chiu K; Pedraza M; Anderson S; Harris R; Dellamary L; Kc S; Barroga C; Melchior B; Tam B; Kennedy S; Tambiah J; Hood J; Yazici Y
Osteoarthritis Cartilage; 2019 Sep; 27(9):1347-1360. PubMed ID: 31132406
[TBL] [Abstract][Full Text] [Related]
13. Intraarticular corticosteroid for treatment of osteoarthritis of the knee.
Bellamy N; Campbell J; Robinson V; Gee T; Bourne R; Wells G
Cochrane Database Syst Rev; 2005 Apr; (2):CD005328. PubMed ID: 15846755
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.
Langworthy MJ; Conaghan PG; Ruane JJ; Kivitz AJ; Lufkin J; Cinar A; Kelley SD
Adv Ther; 2019 Jun; 36(6):1398-1411. PubMed ID: 30968336
[TBL] [Abstract][Full Text] [Related]
15. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
16. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
[TBL] [Abstract][Full Text] [Related]
17. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Roman-Blas JA; Castañeda S; Sánchez-Pernaute O; Largo R; Herrero-Beaumont G;
Arthritis Rheumatol; 2017 Jan; 69(1):77-85. PubMed ID: 27477804
[TBL] [Abstract][Full Text] [Related]
18. The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies.
Saltzman BM; Leroux T; Meyer MA; Basques BA; Chahal J; Bach BR; Yanke AB; Cole BJ
Am J Sports Med; 2017 Sep; 45(11):2647-2653. PubMed ID: 28027657
[TBL] [Abstract][Full Text] [Related]
19. Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis.
Conrozier T; Eymard F; Chouk M; Chevalier X
BMC Musculoskelet Disord; 2019 Aug; 20(1):376. PubMed ID: 31421686
[TBL] [Abstract][Full Text] [Related]
20. Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial.
Petterson SC; Plancher KD
Knee Surg Sports Traumatol Arthrosc; 2019 Jun; 27(6):1992-2002. PubMed ID: 30159738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
